Protracted Course of Relapsing-Remitting Fibrolamellar Hepatocellular Carcinoma in an Adolescent

Ankit Rao, Syed Nadir Abbas, Yuk Ting Ma, Pankaj Punia

Abstract


Hepatocellular carcinoma (HCC) is a global healthcare problem commonest in males with hepatic cirrhosis or hepatitis B virus infection. Fibrolamellar HCC is a subtype seen mainly in younger patients without conventional risk factors and perhaps has a somewhat more favorable prognosis than typical HCC. Here we report a case of fibrolamellar HCC presenting in an adolescent with a prolonged, relapsing-remitting course characterized by prolonged exposure to sorafenib including in the adjuvant context, use of adjuvant doxorubicin chemotherapy, resection of multiple metachronous pulmonary metastases and dramatic response to radiotherapy delivered as tomotherapy to her metastatic hilar lymphadenopathy. We speculate on the possible synergistic interactions between radiotherapy and her anti-angiogenic therapy and on what systemic treatment options might be open to her in the future including further targeted therapy and also immunotherapy including immune checkpoint blockade such as anti-CTLA4 and PD-1.




J Med Cases. 2015;6(3):113-118
doi: http://dx.doi.org/10.14740/jmc2060w

Keywords


Fibrolamellar; Hepatocellular; Carcinoma

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.